chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Knotted muscle; Tense muscle; Throat causing a sore throat; Fever; Viral infection which is similar to strep; Pain at injection site; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE NODULE (Knotted muscle), MUSCULOSKELETAL STIFFNESS (Tense muscle), VIRAL INFECTION (Viral infection which is similar to strep), OROPHARYNGEAL PAIN (Throat causing a sore throat) and VACCINATION SITE PAIN (Pain at injection site) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No prior medical history was reported).    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced VACCINATION SITE PAIN (Pain at injection site). On 19-Mar-2021, the patient experienced VIRAL INFECTION (Viral infection which is similar to strep). On an unknown date, the patient experienced VACCINATION SITE NODULE (Knotted muscle), MUSCULOSKELETAL STIFFNESS (Tense muscle), OROPHARYNGEAL PAIN (Throat causing a sore throat) and PYREXIA (Fever). At the time of the report, VACCINATION SITE NODULE (Knotted muscle), MUSCULOSKELETAL STIFFNESS (Tense muscle), VIRAL INFECTION (Viral infection which is similar to strep), OROPHARYNGEAL PAIN (Throat causing a sore throat), VACCINATION SITE PAIN (Pain at injection site) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  Treatment details included the use of  prednisone and penicillin.   Most recent FOLLOW-UP information incorporated above includes: On 05-Apr-2021: As per the follow-up document received on 05 Apr 2021, the route of administration, anatomical location additional events and treatment details has been added.
malaise; tired/fatigue; everything was "turning black"; blood pressure had bottomed out to 80/52; slumped over; This is a spontaneous report from a contactable Nurse (patient mother). A 17-years-old non pregnant female patient received first dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration, administered in Arm Right on 11Apr2021 13:15 (Batch/Lot number was not reported) (at the age of 17-year-old) for COVID-19 immunisation. The patient had no other medical history. Patient had no covid prior vaccination. Patient did not receive any other vaccines within 4weeks. Concomitant medications included sulfamethoxazole, trimethoprim (BACTRIM) taken for an unspecified indication, start and stop date were not reported. The patient previously took clindamycin and experienced allergy. On 11Apr2021 13:30 the patient experienced malaise, tired, everything was "turning black", blood pressure had bottomed out to 80/52, fatigued, slumped over. Approximately 5-10 minutes post vaccination, patient began to appear malaise. She complained that she felt extremely tired. Next, she stated that everything was "turning black". The pharmacist who gave the vaccine was no where to be found. Patient mother ran and got the NP at the clinic w/in the pharmacy to check her BP. NP stated to mother that she could not hear a BP. Patient mother asked if she could use her stethoscope to hear a BP, as patient mother a RN. Her blood pressure had bottomed out to 80/52. We got her feet up quickly as she was beginning to look very fatigued and slumped over. Patient mother continued to check her blood pressure after the NP left daughter and patient mother in the waiting area to go and continue to see her other clinic pts. Patient mother called 911 to get her daughter some medical assistance as patient mother was starting to panic. Patient mother continued checking her bp that came up to 82/50 and another recheck of 100/60. The EMT arrived maybe 5 min or so later. She continued to have the normal fatigue x2 days. AE resulted in Doctor or other healthcare professional office/clinic visit. AE treatment included called EMT to vaccine site, hydrated, feet elevated to recover blood pressure back to normal limits. The patient did not tested covid post vaccination. Outcome of the events was recovered in 2021.   Information about lot/batch number has been requested.
headache that is bothering her/ a middle headache on the day of the vaccination but it went away; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache that is bothering her/ a middle headache on the day of the vaccination but it went away) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 091d21a) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Oct-2021, the patient experienced HEADACHE (headache that is bothering her/ a middle headache on the day of the vaccination but it went away). On 21-Oct-2021, HEADACHE (headache that is bothering her/ a middle headache on the day of the vaccination but it went away) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Relevant concomitant medications were not reported.  Treatment medication information was not provided.
Information has been received from a registered nurse concerning a male who on Jul 09 2004 was vaccinated with pneumococcal 23v polysaccharide vaccine (lot 648139/0009P). Subsequently, the patient developed redness, warmth, soreness and a raised area at injection site. the patient was recommended ice and acetaminophen (Tylenol) for treatment. The patient recovered. No product quality complaint involved. No further complaints were reported. it was also reported the another patient had a similar reaction (WAES0407USA01676). Additional information is not expected.
Patient states, noticed lump on left side of neck (anterior cervical lymph node) swollen, and tender with deep palpation.  Sudden onset upon waking up with no gradual increase or decrease in size or change of status.  Did not get seen or evaluated until 11 days from initial onset, 14 days from date of vaccination.
prolonged bruising at injection site that last more than 7 days, chronic lung pain, coughing, phlegm
Information has been received from a physician concerning a 60 year old male with a history of  mouth sores who was vaccinated with a dose of ZOSTAVAX and developed "prolonged mouth sores". No further information was provided regarding this adverse experience. Unspecified medical attention was sought. The outcome was reported as recovered. There was no product quality complaint. Additional information is expected.
Tightness in chest; Weird heartbeat; Tingling/numbing sensation on face; Tingling/numbing sensation on face; Dizziness; Confused/trouble focusing; Confused/trouble focusing; Nausea; Pain at injection site; Chills; Headache; Itchy face; Tired; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 15Apr2021 at 14:45 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included migraines and lower back pain. The patient had no other issues. The patient had latex allergy, no known allergies but suspected soft shell crab, shrimp allergy, allergy to something in some surgical masks and nitrile gloves ("must special order for work"), skin reaction and headaches to some fragrances, deodorants, lotions, etc. and potentially developing seasonal allergies recently. The patient had never tested for allergies. Concomitant medications included acetylsalicylic acid/ caffeine/ paracetamol (EXCEDRIN) for migraine on an unknown date and bismuth subsalicylate (PEPTO BISMOL) for an unknown indication from an unknown date; both were unknown if ongoing. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received flu vaccine (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and experienced dizziness and nausea twice which passed within 15 minutes. On 15Apr2021 at 14:45, immediately after the vaccination, the patient experienced tightness in chest, weird heartbeat, tingling/numbing sensation on face, dizziness, confused/trouble focusing, nausea, pain at injection site and later the patient experienced chills, headache, nausea, itchy face, pain at injection site and was tired. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events tightness in chest, weird heartbeat, tingling/numbing sensation on face, dizziness, confused/trouble focusing, nausea, pain at injection site, chills, headache, itchy face and tired were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Coughing up white sputum, severe sinus pain and pressure. Took a full course of Augmentin and symptoms went away minus the cough. Returned for a followup and was recommended to take Flonase to reduce nasal inflammation. Sinus pain returned a week later, took a course of Doxycycline, and pain localized to just above tooth #4. Tooth pain increased severely at night and visited dentist two days later. Had a follow up with my endodontist two days after that, and a root canal was recommended. Had the root canal two days later. Pain is now gone.
PATIENT RECEIVED A DOSE OF PFIZER BIVALENT BOOSTER DOSE WAS PAST BUD, SPOKE TO PATIENT  AND SHE STATED HAS NOT EXPERIENCING ANY ADVERSE EVENTS
The patient called the clinic and reported she developed "tightness of the chest" shortly after the shot was administered. The patient states she had the same reaction one week ago after she received her fist dose. The patient failed to report this to the nurse during the medical history inquiry. The patient saw the PMD last week and he told her it was inflammation of cartilage between the ribs. The patient was treated with an anti-inflammatory.
Redness of arm after injection. 11-9-10 Fever, N & V, lethargic. MD recommended TYLENOL & Ibuprofen & lukewarm baths. Push fluids. 11-10-10 (R) arm swollen & red at injection site.
5/31 patient developed chest pain while at work, presented to clinic at work. Had ECG changes, and MI was suspected, received SL NTG. 35 minutes after nitro she collapsed pulseless and apneic, cyanotic with agonal breathing and posturing. CPR initiated, external defibrillator was used with CPR device- received 4 shocks which failed. Spontaneously converted to sinus rhythm with restoration of pulse, awoke intact neurologically. Transferred to Hospital, underwent emergent LHC, did not show infarction and had normal epicardial anatomy. TTE was normal. CTA confirmed LLL small Pulmonary Embolism. Was started on Xarelto. She had an NSTEMI type II subendocardial injury secondary to V. fib arrest in context of PE or arrhythmia. Lab tests done during admission significant for mild transaminitis with AST 132, ALT with 36 ALP 51, triglycerides 608 unable to calculate LDL, beta-2 glyco 1 IgG normal at less than 9, lupus anticoagulant not detected, double-stranded DNA antibody 2 which is normal, ANA not detected, cardiolipin antibody IgG less than 10 which is normal, cardiolipin antibody IgM less than 10 which is normal, complete blood count unremarkable. Cardiac MRI with scar likely secondary to myocarditis. Started by cardiology on colchicine. Unknown etiology for pulmonary embolism, perhaps result of arrest/cpr.  Had ICD placed.
Fever at 24 hrs.  Diarrhea at 48 hrs of vaccination.  Moderate hypernatremic dehydration.  Hospitalized for IV rehydration.  5/29/08 Reviewed PCP medical records & vax record which confirms vax as reported.  Patient w/sickle/beta (+) thalassemia otherwise in good health & progressing well on day of vax.  5/29/08 Reviewed hospital medical records for 5/19-5/22/2008. FINAL DX: hypertonic dehydration; metabolic acidosis; diarrhea; hemoglobinopathy. Records reveal patient experienced fever, vomiting, watery diarrhea & lethargy day after receiving vaccines.  Improved & d/c to home on oral PCN for hemoglobinopathy & to f/u by heme & PCP.
Passed out; Had three staples put in for a crack on her head; Extremely weak/Could hardly get up; Arms and legs were tingling; Lips were tingling; Doctors thought it might be anxiety;Sense of dread/ felt like something was wrong; Blood pressure was really low; Could not breath well; Felt a little sore; vomited; Nauseous; A spontaneous report was received from a consumer concerning a 55-year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced passed out/loss of consciousness, had three staples put in for a crack on her head/skin laceration, extremely weak-could hardly get up/asthenia, arms and legs were tingling/paraesthesia, lips were tingling/paraesthesia oral, doctors thought it might be anxiety; sense of dread/ felt like something was wrong/anxiety, blood pressure was really low/hypotension, could not breath well/dyspnea, felt a little sore/myalgia, nausea and vomiting.  The patient's medical history we not reported. No relevant concomitant medications were reported.  On 11 Mar 2021, prior to the onset of the events, the patient received the first of two planned doses of mRNA-1273 (Lot number: 030A21A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.   On 11 Mar 2021, within 10 minutes of receiving the vaccine, she passed out which is considered medically significant. Paramedics came and she went to ER (emergency room) where she had three staples put in for a crack on her head. She states she was extremely weak and could hardly get up. She was nauseous, had not eaten for hours and vomited. She states her lips, arms and legs were tingly and that it came in waves for a few hours.  The doctors thought it might have been anxiety. She stated that she had a sense of dread after getting the vaccine like something was wrong. She states that her blood pressure was really low. She also felt a little sore and could not breath well after the vaccine.  Treatment for the events were none. Only had three staples put in for a crack on her head.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events, loss of consciousness, skin laceration, asthenia, paraesthesia, paraesthesia oral, anxiety, hypotension, dyspnea, myalgia, nausea and vomiting were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Caller is a medical assistant and got her third Pfizer covid vaccine and has been sick ever since; headache; nausea; fatigue; joint pain; she got the third dose of the Pfizer COVID-19 vaccine; she got the third dose of the Pfizer COVID-19 vaccine; This is a spontaneous report from a contactable Other HCP (Patient herself). A female patient of an unspecified age received third dose of BNT162B2 (PFIZER-BIONTECH COVID-19 (mRNA) VACCINE, formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 19Aug2021 as single dose for COVID-19 immunisation. The patient medical history and concomitant medications was not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 1, single and received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunisation and states that she has had no problem from the first or second vaccine. On 19Aug2021, she got the third dose of the Pfizer COVID-19 vaccine. On 20Aug2021, the patient experienced caller is a medical assistant and got her third Pfizer COVID vaccine and has been sick ever since, headache, nausea, fatigue and joint pain.  As per the report, she got the third dose of the Pfizer COVID-19 vaccine and stated that she has been sick ever since. She stated that she has had no problem from the first or second vaccine. She stated that she got the vaccine on 19Aug2021 and since 20Aug2021 she has had a headache and nausea Friday-Sunday. She states that she is still have fatigue and joint pain, and that she really hasn't felt right since the third dose. She stated that she didn't have any problems from the first or second dose but the third one threw her for a loop. She wanted to know if this is going to go away or is it something permanent? She stated that she talked to her doctors and they told her to call Pfizer. She stated that she had stuff to treat her symptoms with but it is not doing any good. The outcome of event fatigue and joint pain was not recovered and outcome of all other events was unknown.    Information on the lot/batch number has been requested.
Patient received an undiluted 0.3mL of the pediatric COVID-19 vaccine(Orange Cap). Patient did not experience any side effects immediately after administering the vaccine. Patient's status after leaving the pharmacy is currently unknown
Within 6 hours developed sore arm, fever, chills, hot flashes, nausea, stomach pain, headache, brain fog, fatigue, muscle pain. Tinnitus worsened. 8 days post shot, I have brain fog, headache, muscle pain, fatigue, nausea, stomach pain, worsened Tinnitus, sporadic Nystagmus in right eye and vertigo (sporadic & mild.   I am in between PCP?s & disabled by CPTSD. I contacted a Dr. on Monday about my symptoms & he said he would refer me to an ENT & for lab work. I haven?t received confirmation from my insurance
Hypertension (systolic over 180). Treatment is addition of a second blood pressure medication. I have had onset of hypertension approximately 2 weeks after the first dose of the Moderna vaccine, and now again 2 weeks after the second dose. Note that I take losarten daily, and this event reflects sudden, uncontrolled hypertension onset two weeks after vaccination while on medication, with no other identifiable causes (sodium/caffeine intake was reduced after first AE).
I started feeling weird in my head, terrible ringing in my ears like 10x's worse than normal, spaced out that I can hardly function,  dizziness, misplacing things, disoriented, left eye twitching, vision is more blurry than normal.  (patient stated she didn't know if she can live like this because it makes her want to take her life)
1/17---Flu-like symtoms, fever 101.4 ---Called Dr. who recommended Tylenol and rest 1/18---Bad headache, fever 99.6---still taking tylenol
Pale and woozy/dizzy afer MCV4 followed by sleepiness.  Instant migraine-intensity headache that remitted quickly.  Some word slurring.  Pox 95% and BP's with sys in upper 80's.  Redness at injection site marks and fading quickly.  Some repeat ausculation with good air movement.  Color improving since  first came into room to time returned with popsicle.  Improved enough to leave clinic quickly once started to improve.
pt recvd vax & in the middle of noc pt awoke w/ache radiating down lt arm from the approx site of adm to the lt hand; pain in lt arm;
irritability, collapse, hyperpyrexia (105-106), cyanosis & unresponsiveness;
Patient had positive COVID test 12/18/2020 and had the COVID vaccine 1/5/21. THis may have been too soon, as she presented to ER on 1/10/21 with N/V and new dx of left leg DVT. Could or could not have been related to vaccine vs recent COVID infection, not sure.   Other Relevant Hx:   Phlebitis & Nausea Vomitin
Hives started about 2 hours post flumist vaccine. Started on face and chest; also c/o itchy scalp. Also slight swelling around chin. No difficulty breathing noted.
No signs or symptoms reported; PEDVAX HIB was administered to patients after the excursion occurred; This spontaneous report was received from a licensed practical nurse referring to a patient of unknown age and gender. Information about pertinent medical history, drug reaction/allergy and concomitant medication was not provided.   On 26-OCT-2021, haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) experienced temperature excursion with 35.0 Fahrenheit degrees (F), 35.1 F, 35.3 F, 35.2 F, 34.9 F for 53 minutes (cumulative). There was no previous temperature excursion. On an unknown date in 2021, after the excursion occurred, the patient was vaccinated with the improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) (1 time dose, lot # U003873, expiration date 15-APR-2023; strength, route of administration and anatomical location were not reported) for prophylaxis (product storage error). No signs or symptoms reported. No other adverse event (AE) or product quality complaint (PQC) was reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2111USA004277: US-009507513-2112USA003881: US-009507513-2112USA003882: US-009507513-2112USA003884: US-009507513-2112USA003885:
This spontaneous report was received from a healthcare worker refers to multiple unknown patients of unknown age and gender. Medical history, concurrent conditions and concomitant medication were not reported. On multiple unknown dates, patients were vaccinated with improperly stored (temperature: 1.3C, for 1 hour and 30 minutes, because of a "data logger") ROTATEQ, lot # L033545, exp: 30-MAY-2017; lot # L039141, exp: 08/16/2017; lot # L020861, exp: 25-JAN-2017, (dose and frequency not reported). No adverse effects were reported. No previous temperature excursion was reported. The outcome of the events was unknown. No product quality complaint (PQC) was involved. This is one of three reports received from the same reporter. Additional information has been requested.
Headache; Not feeling very good; This is a spontaneous report from a contactable consumer (patient himself). A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiry date not reported), via an unspecified route of administration on 21Jan2021 at a single dose for COVID-19 immunization. The patient's medical history was not reported. Concomitant medications included other 8 medications (unspecified). Patient received the vaccine this morning, on 21Jan2021, and was wondering if he can take his other 8 medications after receiving the vaccine. Patient was asking if he can take aspirin if he has had a headache after receiving the vaccine (21Jan2021). Patient asked if he can use antipyretics before or after vaccination with the Pfizer-BioNTech COVID-19 vaccine. Patient had his 1st dose of vaccine today and asking if he can take his other prescription drugs including Aspirin for headache. He mentioned he was not feeling very good (21Jan2021). The outcome of the events headache and not feeling very good was unknown.   Information about lot/batch number has been requested.